$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| ASTRAZENECA INCREASES 2024 DIVIDEND BY 7% | 11 Apr 2024 |
| RESULT OF AGM | 11 Apr 2024 |
| ENHERTU APPROVED IN US FOR HER2+ SOLID TUMOURS | 08 Apr 2024 |
| IMFINZI IMPROVED OS & PFS IN LIMITED-STAGE SCLC | 05 Apr 2024 |
| VOYDEYA APPROVED IN US | 02 Apr 2024 |
| TOTAL VOTING RIGHTS | 02 Apr 2024 |
| FDA ACCEPTS DATO-DXD BLA FOR BREAST CANCER | 02 Apr 2024 |
| ULTOMIRIS APPROVED IN THE US FOR NMOSD | 25 Mar 2024 |
| FORM 6-K | 19 Mar 2024 |
| ASTRAZENECA TO ACQUIRE AMOLYT | 14 Mar 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 12 Mar 2024 |
| FORM 6-K | 07 Mar 2024 |
| NOTICE OF AGM | 07 Mar 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 06 Mar 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 06 Mar 2024 |
| EMA VALIDATES DATO-DXD MAAS FOR NSQ NSCLC AND BC | 04 Mar 2024 |
| TOTAL VOTING RIGHTS | 01 Mar 2024 |
| FORM 6-K | 26 Feb 2024 |
| VOYDEYA RECOMMENDED FOR EU APPROVAL | 26 Feb 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 22 Feb 2024 |
